Keyword: Johnson & Johnson
News
06.08.2020
-
Johnson & Johnson (J&J) has struck a deal with the US government worth just over $1 billion to supply 100 million doses of subsidiary Janssen’s SARS-CoV-2 investigational...
News
29.07.2020
-
European officials recently began talking to companies developing Covid-19 vaccines about supplying the EU’s 27 member states, in hope that none would fall behind bigger...
News
28.07.2020
-
Through an acquisition dating back 14 years, BASF is embroiled in the same type of litigation trap as compatriot Bayer currently faces. The Ludwigshafen group’s US...
News
14.07.2020
-
The UK will not participate in a plan to distribute a potential coronavirus vaccine to Europe’s most vulnerable citizens first. Tim Barrow, the UK’s ambassador to the EU...
News
21.05.2020
- As lawsuits against Johnson & Johnson (J&J) claiming its iconic baby powder causes cancer continue to mount, the US healthcare giant has announced plans to pull the talc-based...
Strategy & Management
15.04.2020
- The pharmaceutical industry has been slowly, but surely, embracing continuous manufacturing (CM) over the past decade. In fact, most large pharma companies have invested in...
News
13.01.2020
- A new study published in the Journal of the American Medical Association (JAMA), which found “no statistically significant association” between genital talc use and ovarian cancer...
News
06.01.2020
- US healthcare giant Johnson & Johnson has been on a roller coaster ride for around two years, and its fortunes – along with its share price – continued moving up and down as 2019...